WORLD JOURNAL OF PLASTIC SURGERY
Tue, Apr 29, 2025
[Archive]
Volume 14, Issue 1 (2025)
WJPS 2025, 14(1): 79-84 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Pazyar N, Hajati H, Yaghoobi R, Bakhtiari N. Evaluation of the Efficiency of Microneedling with PRP Versus Microneedling with Tranexamic Acid in the Treatment of Melisma. WJPS 2025; 14 (1) :79-84
URL: http://wjps.ir/article-1-1394-en.html
URL: http://wjps.ir/article-1-1394-en.html
1- Department of Dermatology, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran
2- Department of Pharmacology, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran
2- Department of Pharmacology, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran
Abstract: (343 Views)
Background: Melasma, characterized by irregular skin hyperpigmentation, presents a therapeutic challenge with limited universal solutions. Platelet-rich plasma (PRP) and Tranexamic Acid (TXA), coupled with microneedling, offer promising avenues for treatment. This clinical trial sought to compare the efficacy and adverse effects of microneedling with PRP versus TXA in managing melasma.
Methods: The study was a single-blind, randomized controlled trial from May 2022 to Apr 2023 and enrolled 23 female melasma patients. Using the coin toss method, patients were randomly assigned to receive microneedling with PRP on one side and microneedling with TXA on the other. Evaluation parameters included Melasma Area and Severity Index (MASI) scores, melasma improvement grading, patient satisfaction, and treatment-related side effects, monitored over three sessions at 3-week intervals.
Results: Both microneedling approaches demonstrated effectiveness, with the PRP group exhibiting significantly lower MASI scores at the 6th and 9th wk. However, no significant distinctions were observed in improvement grading or patient satisfaction between the PRP and TXA groups. Side effects were minimal, limited to transient burning and mild pain during the procedure.
Conclusion: Microneedling with PRP and TXA emerged as a safe and effective treatment for melasma. While the PRP group showed potential superiority in MASI scores, comprehensive considerations, including patient preferences and long-term outcomes, are crucial. Larger, multi-center studies with extended follow-up periods are warranted for a more nuanced understanding of these treatments in melasma management.
Methods: The study was a single-blind, randomized controlled trial from May 2022 to Apr 2023 and enrolled 23 female melasma patients. Using the coin toss method, patients were randomly assigned to receive microneedling with PRP on one side and microneedling with TXA on the other. Evaluation parameters included Melasma Area and Severity Index (MASI) scores, melasma improvement grading, patient satisfaction, and treatment-related side effects, monitored over three sessions at 3-week intervals.
Results: Both microneedling approaches demonstrated effectiveness, with the PRP group exhibiting significantly lower MASI scores at the 6th and 9th wk. However, no significant distinctions were observed in improvement grading or patient satisfaction between the PRP and TXA groups. Side effects were minimal, limited to transient burning and mild pain during the procedure.
Conclusion: Microneedling with PRP and TXA emerged as a safe and effective treatment for melasma. While the PRP group showed potential superiority in MASI scores, comprehensive considerations, including patient preferences and long-term outcomes, are crucial. Larger, multi-center studies with extended follow-up periods are warranted for a more nuanced understanding of these treatments in melasma management.
References
1. Miot LDB, Miot HA, Silva MGd, Marques MEA. Physiopathology of melasma. Anais Brasileiros De Dermatologia 2009;84:623-35. [DOI:10.1590/S0365-05962009000600008]
3. Tuknayat A, Thami GP, Bhalla M, Sandhu JK. Autologous intralesional platelet rich plasma improves melasma. Dermatol Ther 2021;34(2):e14881. [DOI:10.1111/dth.14881]
5. Mumtaz M, Chandio TH, Shahzad MK, Hanif N, Anwar S, Rafique S. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma. J Coll Physicians Surg Pak 2021;31(5):502-505. [DOI:10.29271/jcpsp.2021.05.502]
7. Maeda K, Naganuma M. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B 1998;47(2-3):136-41. [DOI:10.1016/S1011-1344(98)00212-7]
9. Hofny ER, Abdel-Motaleb AA, Ghazally A, Ahmed AM, Hussein MRA. Platelet-rich plasma is a useful therapeutic option in melasma. J Dermatolog Treat 2019;30(4):396-401. [DOI:10.1080/09546634.2018.1524821]
11. Sirithanabadeekul P, Dannarongchai A, Suwanchinda A. Platelet‐rich plasma treatment for melasma: a pilot study. J Cosmet Dermatol 2020;19(6):1321-7. [DOI:10.1111/jocd.13157]
13. Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosmet Dermatol 2007;6(3):195-202. [DOI:10.1111/j.1473-2165.2007.00321.x]
15. Çayırlı M, Çalışkan E, Açıkgöz G, Erbil AH, Ertürk G. Regression of melasma with platelet-rich plasma treatment. Ann Dermatol 2014;26(3):401-2. [DOI:10.5021/ad.2014.26.3.401]
17. Perper M, Eber AE, Fayne R, et al. Tranexamic acid in the treatment of melasma: a review of the literature. Am J Clin Dermatol 2017;18:373-81. [DOI:10.1007/s40257-017-0263-3]
19. George A. Tranexamic acid: An emerging depigmenting agent. Pigment Int 2016;3(2):66-71. [DOI:10.4103/2349-5847.196295]
21. Budamakuntla L, Loganathan E, Suresh DH, et al. A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesthet Surg 2013;6(3):139. [DOI:10.4103/0974-2077.118403]
23. Gharib K, Mostafa FF, Ghonemy S. Therapeutic effect of microneedling with platelet-rich plasma versus microneedling with tranexamic acid for melasma. J Clin Aesthet Dermatol 2021;14(8):44.
24. Zhao L, Hu M, Xiao Q, et al. Efficacy and safety of platelet-rich plasma in melasma: a systematic review and meta-analysis. Dermatol Ther 2021;11:1587-97. [DOI:10.1007/s13555-021-00575-z]
26. Pazyar N, Yaghoobi R, Zeynalie M, Vala S. Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma. Clin Cosmet Investig Dermatol 2019:115-22. [DOI:10.2147/CCID.S191964]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
